Hussan Hisham, Gray Darrell M, Hinton Alice, Krishna Somashekar G, Conwell Darwin L, Stanich Peter P
Section of Intestinal Neoplasia and Hereditary Polyposis (INHP), Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Medical Center, 395 W 12th Ave, Suite 240, Columbus, OH, 43210, USA.
Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, USA.
World J Surg. 2016 Apr;40(4):987-94. doi: 10.1007/s00268-015-3358-0.
Morbid obesity (Basic Mass Index ≥ 40 kg/m(2)) leads to increased long-term mortality after colorectal cancer (CRC) surgery. Little is known about its effects on peri-operative CRC surgery outcomes.
85,300 discharges for CRC surgery were identified using the redesigned 2012 National Inpatient Sample. Outcomes of interest were mortality, healthcare charges, and surgical outcomes in morbidly obese patients which were compared to those in nonobese patients.
There were 4385 (5.14%) morbidly obese patients who underwent CRC surgery during the study period. Morbid obesity was associated with younger age, females, and African Americans in our study (p < 0.05). Morbidly obese patients had higher prevalence of CRC peri-operative co-morbidities, surgical complications, and conversions from laparoscopic to open surgery. On multivariate analysis, morbid obesity led to an increased CRC surgery peri-operative mortality (OR 1.85, 95 % CI 1.15, 2.97). Mortality remained significant even after adjusting for surgical complications (OR 1.79, 95 % CI 1.12, 2.88). Morbidly obese patients undergoing CRC also had a prolonged length of hospitalization (1.22 day, 95 % CI 0.67, 1.78), a $15,582 increase in total hospital charges (95 % CI 8419, 22,745), and increased disposition to short-term rehabilitation facilities (OR 2.25, 95 % CI 1.79, 2.84).
Analysis of national level data demonstrates that morbidly obese patients have an increased CRC surgery peri-operative mortality with higher prevalence of co-morbidities, surgical complications, and more health care resource utilization. Future research efforts should concentrate on ameliorating these outcomes in morbidly obese patients.
病态肥胖(基础体重指数≥40kg/m²)会导致结直肠癌(CRC)手术后长期死亡率增加。关于其对结直肠癌手术围手术期结局的影响知之甚少。
使用重新设计的2012年全国住院患者样本确定了85300例结直肠癌手术出院病例。感兴趣的结局是病态肥胖患者的死亡率、医疗费用和手术结局,并与非肥胖患者进行比较。
在研究期间,有4385例(5.14%)病态肥胖患者接受了结直肠癌手术。在我们的研究中,病态肥胖与年轻、女性和非裔美国人相关(p<0.05)。病态肥胖患者结直肠癌围手术期合并症、手术并发症以及从腹腔镜手术转为开放手术的发生率更高。多因素分析显示,病态肥胖导致结直肠癌手术围手术期死亡率增加(比值比1.85,95%可信区间1.15,2.97)。即使在调整手术并发症后,死亡率仍具有统计学意义(比值比1.79,95%可信区间1.12,2.88)。接受结直肠癌手术的病态肥胖患者住院时间也延长了(1.22天,95%可信区间0.67,1.78),总住院费用增加了15582美元(95%可信区间8419,22745),并且入住短期康复机构的倾向增加(比值比2.25,95%可信区间1.79,2.84)。
国家级数据分析表明,病态肥胖患者结直肠癌手术围手术期死亡率增加,合并症、手术并发症的发生率更高,医疗资源利用更多。未来的研究应致力于改善病态肥胖患者的这些结局。